 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol
IDs
|
|
|
| |
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
|
|
|
|
Phase III, Phase II
|
|
|
|
D8480C00013
Eudract Number 2005-003440-66, NCT00384176
|
|
| |
Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003
|
|
|
|
Phase III, Phase II
|
|
|
|
AMT/P2GI/001 Part III
LC001Auron2005, NCT00405561
|
|
| |
Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Chemotherapy
|
|
|
|
Phase III, Phase II
|
|
|
|
CRAD001C2241
NCT00419159
|
|
| |
Flavonoids to Prevent Recurrence in Patients With Resected Colorectal Cancer or Colorectal Adenomas
|
|
|
|
Phase III, Phase II
|
|
|
|
Flav-Hoe-CCC
NCT00609310
|
|
| |
FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer
|
|
|
|
Phase III, Phase II
|
|
|
|
STX0206
NCT00724503
|
|
| |
FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma
|
|
|
|
Phase III, Phase II
|
|
|
|
STX0207
NCT00735241
|
|
| |
Comparison of Two Types of Surgery in Treating Patients With Rectal Cancer
|
|
|
|
Phase III
|
|
|
|
NMRC-ICR01
EU-99019, NCT00007930
|
|
| |
Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer
|
|
|
|
Phase III
|
|
|
|
NSABP-R-04
NCT00058474, CALGB-NSABP-R-04
|
|
| |
Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
|
|
|
|
Phase III
|
|
|
|
NCRI-FOCUS2
MRC-CR09, EU-20303, NCT00070213
|
|
| |
Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer
|
|
|
|
Phase III
|
|
|
|
FFCD 2000 – 05
CET 815, NCT00126256
|
|
